At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
QLGN Qualigen Therapeutics, Inc.
Closed 11-25 16:00:00 EST
4.78
-0.05
-1.04%
盘后5.10
+0.32+6.68%
19:57 EST
High5.05
Low4.41
Vol174.15K
Open5.05
D1 Closing4.83
Amplitude13.25%
Mkt Cap3.52M
Tradable Cap3.52M
Total Shares736.43K
T/O829.84K
T/O Rate23.66%
Tradable Shares736.00K
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
BRIEF-Univest Securities Announces Successful Closing Of $5.1 Million Private Placement For Qualigen Therapeutics
Qualigen Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.